|
|
||||||||
Brief Report |
From Bounces Road Surgery, Forest Primary Care Centre, London, UK
Correspondence: Corresponding author: Suresh Panjwani, MD, MSc, FRACGP, 4 Harper Close, Southgate, London N14 4ES, United Kingdom (E-mail: sureshpanjwani18{at}hotmail.com)
Discoid lupus erythematosus is a chronic dermatological disease that can lead to scarring, hair loss, and hyperpigmentation changes in skin if it is not treated early and promptly. It has a prolonged course and can have a considerable effect on quality of life. Early recognition and treatment improves the prognosis. The diagnosis is usually made by clinical examination. In some cases histopathology may be required to confirm the diagnosis. The histology is that of an inflammatory interface dermatosis. There is insufficient evidence for which treatment is most effective. Because lesions are induced or exacerbated by ultraviolet exposure, photoprotective measures are important. Potent topical steroids and antimalarials are the mainstay of treatment. Some cases of discoid lupus erythematosus can be refractory to standard therapy; in these cases retinoids, thalidomide, and topical tacrolimus offer alternatives, as do immunosuppressives like azathioprine, cyclosporine, mycophenolate mofetil, and methotrexate.
This article has been cited by other articles:
![]() |
M. A. Bowman and A. V. Neale Women's Physical Health, Mental Health, and Practical Hints for Common Practice Issues J Am Board Fam Med, March 1, 2009; 22(2): 99 - 101. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |